No Data
Alphabet Leaps Over Nvidia, Tesla in Top Stock Options as AI Threatens Search Revenue: Options Chatter
Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook
Leerink Partners Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Raises Target Price to $42
Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took It By Surprise -- Barrons.com
Daily short sale tracking: Palantir's short volume increased by 10 million, with a short sale ratio of 12%
Novo Nordisk Cuts 2025 Outlook. But Why Are Its Shares Rising?